对败血症的实施方法的评估:一个集群随机化混合型2型试验的研究协议
Hannah E Frank1, Laura Evans2, Gary Phillips3
1Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
早期的败血症治疗可以挽救生命. 这项研究比较了1小时捆绑与3小时捆绑在急诊室的败血症管理,以改善患者的结果.
科学领域:
- 关键护理医学 关键护理医学
- 实施科学 实施科学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 败血症是ICU入院和死亡的主要原因.
- 败血症捆绑,就像3小时捆绑一样,是早期管理的国家标准.
- 新出现的数据表明,早期干预 (1小时捆绑) 可能会改善死亡率.
研究的目的:
- 为了评估启动3小时败血症捆绑在1小时内与识别后3小时内的临床结果.
- 评估严格实施策略的有效性,以遵守败血症捆绑.
- 确定败血症表型及其对治疗结果的影响.
主要方法:
- 一个集群随机试验,在18个地点的急诊部进行.
- 在1小时和3小时的败血症捆绑启动之间比较临床结果.
- 利用实施科学框架来提高捆绑合规性.
主要成果:
- 这项研究旨在提供关于1小时败血症捆绑剂有效性的数据.
- 它将量化实施战略对捆绑合规性的影响.
- 二次分析将探索临床败血症表型的作用.
结论:
- 这个集群随机试验使用混合有效性-实施设计.
- 结果将严格评估1小时和3小时的败血症捆绑.
- 预计这项研究将对治疗败血症的临床实践产生重大影响.
更多相关视频
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
相关概念视频
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Randomized Experiments
Simple randomization
Simple...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cluster Sampling Method
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
Clinical Trials
There are four phases in a clinical trial. A phase one...
